Y. Bando

发表

CLD (chronic liver diseases)-HbA1C as a suitable indicator for estimation of mean plasma glucose in patients with chronic liver diseases.

M. Koga, S. Kasayama, H. Kanehara, 2008, Diabetes research and clinical practice.

Determinants of the HbA1c-lowering effect of sitagliptin when added to ongoing insulin therapy in Japanese patients with type 2 diabetes

H. Kanehara, Y. Bando, Kazuhide Ishikura, 2013, Diabetology International.

Ipragliflozin lowers small, dense low-density lipoprotein cholesterol levels in Japanese patients with type 2 diabetes mellitus

H. Kanehara, Y. Bando, Keiko Aoki, 2016, Journal of clinical & translational endocrinology.

Serum CETP status is independently associated with reduction rates in LDL-C in pitavastatin-treated diabetic patients and possible involvement of LXR in its association

T. Wakasugi, K. Oida, H. Kanehara, 2016, Lipids in Health and Disease.

Is glycated albumin useful for differential diagnosis between fulminant type 1 diabetes mellitus and acute-onset autoimmune type 1 diabetes mellitus?

M. Koga, S. Kasayama, H. Kanehara, 2015, Clinica chimica acta; international journal of clinical chemistry.

Pancreatic exocrine and endocrine events occur concomitantly but independently during the course of fulminant type 1 diabetes.

S. Kaneko, T. Hayakawa, H. Misu, 2006, Diabetes research and clinical practice.

Switching from atorvastatin to rosuvastatin lowers small, dense low-density lipoprotein cholesterol levels in Japanese hypercholesterolemic patients with type 2 diabetes mellitus.

H. Kanehara, Y. Bando, A. Hisada, 2016, Diabetes research and clinical practice.

Liver fibrosis markers of nonalcoholic steatohepatitis.

Hideji Nakamura, M. Koga, Y. Bando, 2015, World journal of gastroenterology.

Non-high-density cholesterol level as a predictor of maximum carotid intima-media thickness in Japanese subjects with type 2 diabetes: a comparison with low-density lipoprotein level

H. Kanehara, Y. Bando, Keiko Aoki, 2016, Diabetology International.

Chronic hyperglycemia may attenuate the serum-uric-acid-lowering effect of low-dose febuxostat in Japanese patients with type 2 diabetes mellitus

H. Kanehara, Y. Bando, A. Hisada, 2016, Diabetology International.

Predictive clinical parameters for the hemoglobin A1c-lowering effect of vildagliptin in Japanese patients with type 2 diabetes

H. Kanehara, Y. Bando, Masayuki Yamada, 2014, Diabetology International.

Renoprotective effects of atorvastatin compared with pravastatin on progression of early diabetic nephropathy

S. Kaneko, T. Hayakawa, H. Misu, 2014, Journal of diabetes investigation.

1,5-Anhydroglucitol levels are low irrespective of plasma glucose levels in patients with chronic liver disease

H. Saito, M. Koga, S. Kasayama, 2011, Annals of clinical biochemistry.

Three diabetic cases of acute dizziness due to initial administration of voglibose.

Y. Bando, N. Tanaka, Y. Ushiogi, 1998, Internal medicine.

Glycemic control indicator levels at diagnosis of neonatal diabetes mellitus: Comparison with other types of insulin‐dependent diabetes mellitus

H. Azuma, M. Koga, S. Kasayama, 2017, Pediatric diabetes.

The glycated albumin to glycated haemoglobin ratio increases along with the fibrosis stage in non-alcoholic steatohepatitis

K. Nakasho, Hideji Nakamura, M. Koga, 2012, Annals of clinical biochemistry.

Myxedema ascites with an extremely elevated CA125 Level: a case report.

H. Kanehara, Y. Bando, N. Tanaka, 2007, Endocrine journal.

Serum albumin-adjusted glycated albumin is an adequate indicator of glycemic control in patients with Cushing's syndrome.

I. Shimomura, M. Koga, S. Kasayama, 2014, Clinical biochemistry.

Association of serum glycated albumin to haemoglobin A1C ratio with hepatic function tests in patients with chronic liver disease

M. Koga, S. Kasayama, H. Kanehara, 2009, Annals of clinical biochemistry.

Exacerbation of hypothyroidism following tumor necrosis factor-alpha infusion.

Y. Bando, H. Yokoyama, Y. Nagai, 1992, Internal medicine.

Cyclosporine A (CyA)-induced decrease of serum gonadotropin levels in a case of Klinefelter's syndrome.

Y. Bando, N. Tomosugi, H. Yokoyama, 1991, Nihon Naibunpi Gakkai zasshi.

Development of Graves' hyperthyroidism from primary hypothyroidism in a case of thyroid hemiagenesis.

Y. Bando, N. Tanaka, Y. Nagai, 1999, Thyroid : official journal of the American Thyroid Association.

Troglitazone Combination Therapy in Obese Type 2 Diabetic Patients Poorly Controlled with α-Glucosidase Inhibitors

Y. Bando, N. Tanaka, K. Okafuji, 1999, The Journal of international medical research.

Obesity may attenuate the HbA1c‐lowering effect of sitagliptin in Japanese type 2 diabetic patients

H. Kanehara, Y. Bando, Keiko Aoki, 2011, Journal of diabetes investigation.

Characteristics of undiagnosed diabetes mellitus in a population undergoing health screening in Japan: target populations for efficient screening.

H. Kanehara, Y. Bando, K. Katoh, 2009, Diabetes research and clinical practice.

Painless Thyroiditis Reactions in Amyloid Associated with Severe Goiter : A Case Report Inflammatory

Y. Bando, D. Toya, N. Tanaka, 2006 .

Painless thyroiditis associated with severe inflammatory reactions in amyloid goiter: a case report.

Y. Bando, N. Tanaka, Y. Ushiogi, 2001, Endocrine journal.

The relationship of fasting plasma glucose values and other variables to 2-h postload plasma glucose in Japanese subjects.

Y. Bando, D. Toya, N. Tanaka, 2001, Diabetes care.

The effects of ipragliflozin on the liver-to-spleen attenuation ratio as assessed by computed tomography and on alanine transaminase levels in Japanese patients with type 2 diabetes mellitus

H. Kanehara, Y. Bando, Kazuhide Ishikura, 2017, Diabetology International.

Non-autoimmune primary hypothyroidism in diabetic and non-diabetic chronic renal dysfunction.

Y. Bando, N. Tanaka, K. Okafuji, 2003, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Antibodies to glutamic acid decarboxylase (GAD) in non-obese Japanese diabetics without insulin therapy: a comparison of two commercial RIA kits based on recombinant and pig brain GAD.

Y. Bando, N. Tanaka, Y. Ushiogi, 1998, Diabetes research and clinical practice.

Efficacy and Safety of Insulin Glulisine in Intensive Insulin Therapy: Bolus Insulin Adjust Nice Control by apiDRA Study (BANDRA Study)

Yukihiro Bando, Keiko Aoki, Kousuke Shima, 2015 .

Serum CETP status is independently associated with reduction rates in LDL-C in pitavastatin-treated diabetic patients and possible involvement of LXR in its association

T. Wakasugi, K. Oida, H. Kanehara, 2016, Lipids in Health and Disease.

Surgical stress‐induced transient nephrogenic diabetes insipidus (NDI) associated with decreased Vasopressin receptor2 (AVPR2) expression linked to nonsense‐mediated mRNA decay and incomplete skewed X‐inactivation in a female patient with a heterozygous AVPR2 mutation (c. 89–90 delAC)

H. Mabuchi, Y. Bando, M. Demura, 2004, Clinical endocrinology.

Significance of IA-2 antibody in Japanese type 1 diabetes: its association with GAD antibody.

T. Takamura, Y. Bando, T. Ota, 2005, Diabetes research and clinical practice.

Papillary carcinoma of the thyroid with distant metastases to the cerebrum: a case report.

Y. Bando, Y. Kasahara, N. Tanaka, 2001, Japanese journal of clinical oncology.

[The frequency and mechanisms of urolithiasis in acromegaly].

Y. Bando, Y. Nagai, Y. Ieki, 1991, Nihon Naibunpi Gakkai zasshi.

[A case of pseudohypoparathyroidism (PHP) type II associated with Bartter's syndrome--restoration of phosphaturic response to parathyroid hormone (PTH) by treatment for hypopotassemia].

Y. Bando, T. Nagaoka, K. Kobayashi, 1992, Nihon Naibunpi Gakkai zasshi.

Association of serum glycated albumin to haemoglobin A1C ratio with hepatic function tests in patients with chronic liver disease

M. Koga, S. Kasayama, Y. Bando, 2009, Annals of clinical biochemistry.